Kg Increase In Weight Research Articles

How does weight gain since the age of 18 years affect breast cancer risk in later life? A meta-analysis

Early life factors are important risk factors for breast cancer. The association between weight gain after age 18 and breast cancer risk is inconsistent across previous epidemiologic studies. To evaluate this association, we conducted a meta-analysis according to PRISMA guidelines and the established inclusion criteria. We performed a comprehensive literature search using Medline (Ovid), Embase, Scopus, Cochrane Library, and ClinicalTrials.gov to identify relevant studies published before June 3, 2022. Two reviewers independently reviewed the articles for final inclusion. Seventeen out of 4,725 unique studies met the selection criteria. The quality of studies was assessed using the Newcastle-Ottawa Scale (NOS), and all were of moderate to high quality with NOS scores ranging from 5 to 8. We included 17 studies (11 case-control, 6 cohort) in final analysis. In case-control studies, weight gain after age 18 was associated with an increased risk of breast cancer (odds ratio [OR] = 1.25; 95% CI = 1.07–1.48), when comparing the highest versus the lowest categories of weight gain. Menopausal status was a source of heterogeneity, with weight gain after age 18 associated with an increased risk of breast cancer in postmenopausal women (OR = 1.53; 95% CI = 1.40–1.68), but not in premenopausal women (OR = 1.01; 95% CI = 0.92–1.12). Additionally, a 5 kg increase in weight was positively associated with postmenopausal breast cancer risk (OR = 1.12; 95%CI = 1.05–1.21) in case-control studies. Findings from cohort studies were identical, with a positive association between weight gain after age 18 and breast cancer incidence in postmenopausal women (relative risk [RR] = 1.30; 95% CI = 1.09–1.36), but not in premenopausal women (RR = 1.06; 95% CI = 0.92–1.22). Weight gain after age 18 is a risk factor for postmenopausal breast cancer, highlighting the importance of weight control from early adulthood to reduce the incidence of postmenopausal breast cancer.

The relationship between demographic factors and syncopal symptom in pediatric vasovagal syncope

This research proposed to retrospectively analyze 20 years of clinical data and investigate the relationship between demographic factors and syncopal symptom in pediatric vasovagal syncope. A total of 2513 children, 1124 males and 1389 females, age range 3–18 years, who presented to Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University with unexplained syncope or pre-syncope and were diagnosed with vasovagal syncope were retrospectively collected and divided into syncope group (n = 1262) and pre-syncope group (n = 1251). (1) Females had a 36% increased risk of syncope compared to males, a 27% increased risk of syncope for every 1-year increase in age, and a 2% decreased risk of syncope for every 1 cm increase in height. (2) A non-linear relationship between age, height, weight and syncope was observed. When age > 10.67 years, the risk of syncope increases by 45% for each 1-year increase in age; when height < 146 cm, the risk of syncope decreases by 4% for each 1 cm increase in height; when weight < 28.5 kg, the risk of syncope decreases by 10% for each 1 kg increase in weight. Demographic factors are strongly associated with syncopal symptom in pediatric vasovagal syncope and can help to predict the risk.

Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease.

Weight gain following initiation of antiretroviral therapy (ART) is common. We assessed the impact of changes in weight in the year following ART initiation with subsequent cardiometabolic disease among AIDS Clinical Trials Group (ACTG) participants. Linear regression models were fit to examine the association between change in weight/waist circumference (WC) in weeks 0-48 and change in metabolic parameters in weeks 0-48 and 48-96. Cox proportional hazard models were fit to examine the association between changes in weight/WC in weeks 0-48 and diabetes mellitus (DM), metabolic syndrome, or cardiometabolic and cardiovascular events after week 48. Participants (N = 2624) were primarily male (81%) and non-White (60%). Mean weight gain from 0-48 weeks was 3.6 kg (SD 7.3); 130 participants developed DM; 360 metabolic syndrome; 424 any cardiometabolic event; 28 any cardiovascular event, over 480 weeks of follow-up. In adjusted models, total cholesterol increased by 0.63 mg/dL (95% confidence interval [CI] [.38, .089]) and LDL by 0.39 mg/dL (0.19, 0.59) per 1 kg increase in weight from weeks 0 to48. Participants who experienced >10% weight gain (vs -5% to 5%) had an increased risk of DM (hazard ratio [HR] 2.01, 95% CI [1.30, 3.08]), metabolic syndrome (HR 2.24, 95% CI [1.55, 2.62]), and cardiometabolic outcomes (HR 1.54, 95% CI [1.22, 1.95]). Participants who lost more than 5% of their baseline weight had a lower risk of incident metabolic syndrome (HR 0.67, 95% CI [0.42, 1.07]). Trends for WC were similar. Weight and body composition changes in the first year following ART initiation are associated with contemporaneous changes in metabolic parameters and subsequent cardiometabolic disease.

Ovarian hyperstimulation syndrome following the use of GnRH agonist trigger of final oocyte maturation and freeze–all strategy

Rationale: The current literature has a surprising controversy regarding the use of low-dose human chorionic gonadotropin (hCG) for luteal support as an explanation for the development of ovarian hyperstimulation syndrome, and this is because of the gap in the listing of the predisposing factors that put women at an increased risk of ovarian hyperstimulation syndrome. Patient concerns: A case of 25-year-old woman presented with abdominal pain, distention, dyspnea, and nausea with a 6.5 kg increase in weight from baseline. Ultrasonographic examination showed bilaterally enlarged multicystic ovaries after gonadotropin-releasing hormone (GnRH) agonist triggering and cycle segmentation with no hCG rescue administration. Diagnosis: Moderate/severe ovarian hyperstimulation syndrome. Interventions: The woman was admitted to the hospital for medical management of moderate/severe ovarian hyperstimulation syndrome, and pain management was advanced to patient-controlled anesthesia with the start of low molecular weight heparin. On day 2, albumin therapy followed by a furosemide chase was started due to an increase in abdominal girth. On day 1, Cabergoline was maintained, and on day 2 the GnRH antagonist Cetrorelix was started. Outcomes: The woman’s clinical condition improved, and a clinical pregnancy was eventually achieved during the first cryo-warmed blastocyst cycle. Lessons: Ovarian hyperstimulation syndrome can still happen even after the use of GnRH agonist and avoidance of hCG support. Segmentation of in vitro fertilization with complete avoidance of hCG for luteal support remains the best approach.

WE4.1 A Prospective Observational Study on Quality of Life Pre and Post Gastrojejunostomy for Benign Disease

Abstract Background Benign disease leading to gastric outlet obstruction is a major cause for morbidity and malnutrition. Surgery in the form of a gastrojejunostomy is aimed at improving quality of life by bypassing the obstructing lesion and restoring adequate oral nutrition. Methods Patients undergoing an open gastrojejunostomy for benign disease at a district general hospital operated by the same surgeon over a 3 year period were recruited. Based on the HRQoL SF-12 questionnaire, the pre-operative physical component summary (PCS) score were recorded together with pre-operative albumin levels and weight. The post operative PCS score, post-operative albumin and post-operative weight were recorded at 90 days. Differences were investigated using univariate comparisons. Results The mean ± SD pre-operative PCS score were 33.9 ± 8.1, postoperative score were 42.7 ± 7.8 9 (p= 0.003) in 6 patients. Mean ± SD pre-operative serum albumin levels were 27 ± 4 and postoperative levels were 32 ± 3 (p=0.04). There was a 3.7 ± 1.2 kg increase in weight over the 90 day period (p=0.03). There were no complications nor returns to theatre. The mean length of stay was 6 ± 3 days. Conclusions Gastrojejunostomy for benign disease causing gastric outlet obstruction has been shown to improve quality of life, serum albumin and weight over a 90 day period. It can therefore be concluded that beneficial patient outcomes can be achieved in a relatively short time span post-surgery.

Long-Acting Moxidectin for the Control of Gastrointestinal Nematodes in Preweaned Beef Calves in Tropical Areas

Gastrointestinal nematodes (GINs) in beef calves in the preweaning period can be an underestimated problem, and an adequate control program can result in increased productivity. In the current scenario of anthelmintic resistance, clinical studies with highly effective molecules with a prolonged period of action can contribute to the development of technologies applied in the field. The objective of this study was to evaluate the effects of a 10% moxidectin formulation (10%MOX), administered to calves aged 4–5 months, in the control of gastrointestinal nematodes and weight gain until the time of weaning. The study was divided into 2 stages. The first stage was carried out on a farm, with a randomized block design based on fecal egg counts (FEC), live weight, number of calvings of the mother, breed of the calves, and pickets. In the second stage, the study was repeated on 10 other farms, following a completely randomized design, to confirm the results obtained in the first stage. In all experiments there was a treated group and a placebo group. In the first stage, the effectiveness of 10%MOX in the FECRT performed on the 38th day post-treatment was 98.49%, and the treated animals still had lower FEC averages and a 9.4 kg increase in weight at weaning compared to those from the placebo group. In the second stage, the average increase in weight gain was 6.1 kg, confirming the results of the first stage. The study demonstrated effective control of GINs and improvement in the productive performance of calves treated in the preweaning phase, using 10% moxidectin.

Effects of Corticosteroid Treatment on Mycophenolic Acid Exposure in Renal Transplant Patients-Results From the SAILOR Study.

Background: Mycophenolic acid (MPA) is a potent immunosuppressive agent used in solid organ transplantation. MPA exhibits large interindividual variation in dose-normalized plasma concentrations but is nevertheless usually prescribed as a fixed dose without use of therapeutic drug monitoring (TDM). Data on the effect of corticosteroid (CS) treatment on MPA concentrations during concomitant tacrolimus treatment remains sparse.Methods: Data is based on TDM of MPA area under the concentration curve (AUC) in 210 renal transplant recipients participating in the prospective, randomized, controlled, multi-center trial (SAILOR) where a steroid-free immunosuppressive regimen with mycophenolate mofetil (MMF) and low-dose tacrolimus was compared with a conventional prednisolone-based treatment regimen. Multilevel mixed-effects linear regression post-hoc analyses of MPA AUC was performed.Results: Median MPA AUC at baseline (within the first 2 weeks post-transplant) in patients taking 2 g MMF daily was 53 mg*h/L (interquartile range: 43–69 mg*h/L, min: 24—max: 117 mg*h/L). Between-patient variation in MPA AUC was up to 5-fold on the same MMF dose. Patients in the steroid-free group had 12.5% lower (95% CI; 3.2–20.9%, p = 0.01) MPA AUC levels at baseline compared to the steroid treated group. During follow-up (14 days–2 years post-transplant) there were no significant differences in MPA AUC between the groups with MPA AUC being 4.2% lower (95% CI: −4.8%−12,5%, p = 0.35) in the steroid-free vs standard treatment group in restricted analysis after multivariate adjustment for tacrolimus trough level, body weight, time after transplantation and MMF dose. MMF dose was positively correlated with MPA AUC (p < 0.001) whereas body weight was negatively correlated with MPA AUC (p < 0.001). MPA AUC was 0.4% (95% CI: 0.2–0.6%, p < 0.001) lower per 1 kg increase in weight. Tacrolimus trough levels had no significant effect on MPA AUC.Conclusion: Immunosuppression with CS during concomitant tacrolimus treatment was shortly after transplantation associated with a significantly higher MPA exposure but the effect was small and not maintained during follow-up. Low body weight was associated with higher MPA exposure, which suggests a potential for weight adjusted MMF dosing.

Association Between Weight Change and Leukocyte Telomere Length in U.S. Adults.

ObjectiveTo investigate the association of dynamic weight change in adulthood with leukocyte telomere length among U.S. adults.MethodsThis study included 3,886 subjects aged 36-75 years from the National Health and Nutrition Examination Survey (NHANES) 1999-2002 cycle. Survey-weighted multivariable linear regression with adjustments for potential confounders was utilized.Results3,386 individuals were finally included. People with stable obesity had a 0.130 kbp (95% CI: 0.061-0.198, P=1.97E-04) shorter leukocyte telomere length than those with stable normal weight (reference group) during the 10-year period, corresponding to approximately 8.7 years of aging. Weight gain from non-obesity to obesity shortened the leukocyte telomere length by 0.094 kbp (95% CI: 0.012-0.177, P=0.026), while normal weight to overweight or remaining overweight shortened the leukocyte telomere length by 0.074 kbp (95% CI: 0.014-0.134, P=0.016). The leukocyte telomere length has 0.003 kbp attrition on average for every 1 kg increase in weight from a mean age of 41 years to 51 years. Further stratified analysis showed that the associations generally varied across sex and race/ethnicity.ConclusionsThis study found that weight changes during a 10-year period was associated with leukocyte telomere length and supports the theory that weight gain promotes aging across adulthood.

Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study.

Background: Linezolid is used for the treatment of soft tissue infections in critically ill patients. However, data for characterizing the pharmacokinetics (PK) and assessing whether effective concentrations are reached at the target site are lacking. We hypothesized that current dosing regimens do not lead to effective concentrations in the plasma and interstitial fluid (ISF) of subcutaneous tissue in obese patients. Methods: As a controlled clinical model, critically ill obese and non-obese patients undergoing intra-abdominal surgery received 600 mg linezolid as a single infusion. Concentrations in the plasma and microdialysate from the ISF of subcutaneous tissue were determined up to 8 h after dosing. Pharmacokinetic analysis was performed by non-compartmental methods. As a therapeutic target, we used fAUC/MIC > 80. Results: Fifteen obese (BMI: 48.7 ± 11.2 kg/m2) and 15 non-obese (23.9 ± 2.1 kg/m2) patients were analyzed. AUC0–8 in ISF decreased by −1.69 mg*h/L (95% CI: −2.59 to −0.79, p < 0.001) for every 10 kg increase in weight. PK in obese patients were characterized by lower maximal plasma concentrations (median 3.8 vs. 8.3 mg/L, p < 0.001) and a higher volume of distribution (41.0 vs. 30.8 L, p < 0.001), and the therapeutic target was not reached for MIC ≥ 1 mg/L in ISF and ≥ 2 mg/L in plasma. Conclusions: Increasing the weight led to a decrease of linezolid concentrations in the plasma and subcutaneous tissue. The current dosing regimen does not seem to produce sufficient concentrations to kill bacteria with MIC ≥ 2 mg/L, especially as empirical antimicrobial therapy in critically ill obese patients.

15 Factors affecting the sale price of bred heifers sold through Superior Livestock video auctions from 2010 through 2017

Abstract The objective was to evaluate potential factors influencing sale price of bred heifers sold through a video auction service. Descriptive characteristics of lots were obtained through a livestock video auction service. Data were available on 1,779 lots of bred heifers sold through video auctions from 2010 through 2017. Multiple regression with a backwards selection procedure was used to determine factors influencing sale price. Eleven factors were included in the original model. These were year, weight (linear and quadratic), region, breed description, weight variation, origin, frame score, flesh score, and size of lot (linear and quadratic). Size of lot (linear and quadratic) and weight (quadratic) did not affect sale price (P &gt; 0.05) and therefore were not included in the final model. Breed description of the lots was characterized into five groups: English-English cross, English-Continental cross, Black Angus sired out of dams with no Brahman influence, Red Angus sired out of dams with no Brahman influence, and Brahman influenced. The United States was divided into five regions: West Coast, Rocky Mountain/North Central, South Central, South East, and Northeast, which was excluded from analysis due to few lots originating from this region. Lots of bred heifers sold for the lowest sale price (P &lt; 0.05) in 2010 at $955/head (Table 1). In 2015, lots sold for the highest price (P &lt; 0.05) compared with all other years ($2,725/head). Those lots originating from the Rocky Mountain/North Central region sold for the highest price (P &lt; 0.05, $1,677/head). Red Angus sired lots sold for the highest price (P &lt; 0.05, $1,711/head) compared with all other breed descriptions. There was an $85.00 increase in price for every 45.36 kg increase in weight. Understanding factors influencing sale price of bred heifers will allow producers to make more informed decisions.

Growth in early life and physical and intellectual development at school age: a cohort study.

The associations between growth during early life and subsequent cognitive development and physical outcomes are not widely known in low-resource settings. We examined postnatal weight and height gain through early life and related these measurements to the nutritional status and intellectual development of the same children when they were between 7 and 9 years old. Mothers had enrolled in an randomised controlled trial to evaluate the effect of prenatal micronutrient supplementation on birth weight. Their children were born in 2004, their height and weight were measured at 6, 12, 18 and 24 months of age and were followed up between October 2012 and September 2013 (at ages 7-9 years, n 650). Height-for-age, weight-for-age and BMI-for-age were used to describe the nutritional status, and the Wechsler Intelligence Scale for Children fourth edition was used to measure the intellectual function. Multilevel linear and logistic modelling was used to estimate the association between early growth and subsequent growth and intellectual function. After adjustment, weight gain from 6 to 12 months of age was associated with Full-scale Intelligence Quotient, Verbal Comprehension Index, Working Memory Index and Perceptual Reasoning Index. Weight gain during early life was associated with subsequent nutritional status. For every 1 kg increase in weight during the 0- to 6-month period, the OR for underweight, thinness and stunting at 7-9 years of age were 0·19 (95 % CI 0·09, 0·37), 0·34 (95 % CI 0·19, 0·59) and 0·40 (95 % CI 0·19, 0·83), respectively. Weight gain during the periods of 6-12 months of age and 18-24 months of age was also associated with a lower risk of being underweight. Weight gain during early life was associated with better growth outcomes and improved intellectual development in young school-aged children.

A16787 ACE activity and its expression as a hypertension biomarker in the urine of pediatric renal transplant recipients

Objectives: Analyze ACE isoform in urine of pediatric renal transplant recipients before and after transplantation and urine of donor, to verify the 90 kDa isoform transmission and correlating with hypertension Methods: 30 pediatric recipients with living donors; ACE activity was performed before, 1, 3 and 6 months post transplantation using ZPhe and HHL as substrates and its ratio Results: 69% had pre-transplant hypertension and 85.7% family history. After 6 months 25% remained. From the pre-transplant until the sixth month after, ACE activity was reduced. In the model of linear regression between ACE activity and variables, including pre-transplantation for the substrates ZPhe-HL remained significant, time and uropathy (0.023 more); with HHL, time and uropathy with higher activity of ACE (0.019 more) and for weight, reduction of ACE activity (0.00038 at 1 kg increase in weight). At post-transplant only time and weight remained significant with ZPhe-HL, and for HHL uropathy, proteinuria (0.010 more ACE activity) and weight. Recipients before transplantation had higher urinary ACE activity when compared to controls. Western blotting data showed that all recipients without ACE 90KDa when received a kidney from the donor that had this isoform, started to express it Conclusion: Increased ACE activity in uropathies may be associated with renal injury or intra-renal production. Proteinuria, a marker of renal injury, can be associated with increase on ACE activity. With nutritional recovery and a healthy kidney after transplantation, patients can reverse the degree of renal damage and decrease the production of ACE

Abstract P394: Ace Activity and Its Expression as a Hypertension Biomarker in the Urine of Pediatric Renal Transplant Recipients

Pediatric hypertension is a risk factor for hypertension in adults. Primary hypertension results from genetic, environmental, and behavioral factors. Renin Angiotensin System is important to control cardiovascular and renal functions. Angiotensin Converting Enzyme (ACE) has isoforms: somatic (130-190 kDa) and testicular (90-110 kDa). Casarini et al. described the N-domain isoform of 90kDa, in urine of hypertensive humans as a possible hypertension biomarker. Objective: Analyze ACE isoform in urine of pediatric renal transplant recipients before and after transplantation and urine of donor, to verify the 90 kDa isoform transmission and correlating with hypertension. Methods: 30 pediatric recipients with living donors; ACE activity was performed before, 1, 3 and 6 months post transplantation using ZPhe and HHL as substrates and its ratio. Results: 69% had pre-transplant hypertension and 85.7% family history. After 6 months 25% remained. From the pre-transplant until the sixth month after, ACE activity was reduced. In the model of linear regression between ACE activity and variables, including pre-transplantation for the substrates ZPhe-HL remained significant, time and uropathy (0.023 more); with HHL, time and uropathy with higher activity of ACE (0.019 more) and for weight, reduction of ACE activity ( 0.00038 at 1 kg increase in weight). At post-transplant only time and weight remained significant with ZPhe-HL, and for HHL uropathy, proteinuria (0.010 more ACE activity) and weight. Recipients before transplantation had higher urinary ACE activity when compared to controls. Western blotting data showed that all recipients without ACE 90KDa when received a kidney from the donor that had this isoform, started to express it. Conclusions: Increased ACE activity in uropathies may be associated with renal injury or intra-renal production. Proteinuria, a marker of renal injury, can be associated with increase on ACE activity. With nutritional recovery and a healthy kidney after transplantation, patients can reverse the degree of renal damage and decrease the production of ACE.

Anthropometric factors and non-Hodgkin's lymphoma risk: systematic review and meta-analysis of prospective studies.

The associations between anthropometric factors and non-Hodgkin's lymphoma (NHL) risk remain inconclusive. A meta-analysis was performed to clarify these associations. PubMed and Web of Science were searched for relevant prospective observational studies. A random-effects model was used to generate the summary relative risks (RRs) with 95% confidence intervals (CIs). A total of 22 prospective cohort studies, with over 20,000 NHL cases, were included in the present meta-analysis. The summary RRs of NHL risk were 1.06 (95% CI 1.03, 1.09) for each 5 kg/m2 increase in body mass index (BMI), 1.11 (95% CI 1.07, 1.16) for each 5 kg/m2 increase in BMI in early adulthood (age 18-21 years), 1.05 (95% CI 1.01, 1.09) for each 10 kg increase in weight, 1.21 (95% CI 1.15, 1.28) for each 10 kg increase in weight in early adulthood (age 18-21 years), and 1.13 (95% CI 1.10, 1.17) for each 10 cm increase in height. No association was found for waist circumference (WC) and waist-to-hip ratio. By subtypes, all anthropometric factors (but not WC) were associated with an increased risk of diffuse large B-cell lymphoma. Chronic lymphocytic leukemia/small lymphocytic lymphoma was positively associated with BMI in early adulthood and with height, whereas follicular lymphoma was only positively associated with height. In summary, BMI and weight in early adulthood may be more relevant to NHL development than current BMI and weight. These findings emphasize the importance of maintaining a healthy weight throughout the life-course, starting from early life, for NHL prevention. Increased NHL risk with taller stature, which may reflect cumulative exposure to hormones/growth factors and nutrition status in early life, further supports the relevance of early life exposure in the etiology of NHL.

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin.

BACKGROUND:Diabetes mellitus is a progressive disorder that often requires combination therapy.AIM:This study aimed to compare and study of add-on sitagliptin versus pioglitazone in patients with type 2 diabetes inadequately controlled with metformin.METHODS:This 12-week, randomised, open-label and single centre study compared sitagliptin (100 mg daily, n = 80) and pioglitazone (30 mg daily, n = 80) in type 2 diabetic patients whose disease was not adequately controlled with metformin.RESULTS:The mean change in HbA1c from baseline was -1.001 ± 0.83 with sitagliptin and -0.75 ± 1.20 with pioglitazone, and there were no significant difference between groups (P = 0.132). The mean change in fasting blood sugar (FBS) was -18.48 ± 33.32 mg/dl with sitagliptin and -20.53 ± 53.97 mg/dl with pioglitazone, and there were no significant difference between groups (P = 0.773). Sitagliptin caused 1.08 ± 2.39 kg decrease in weight, whereas pioglitazone caused 0.27 ± 2.42 kg increase in weight, with a between-group difference of 0.81 kg (P < 0.001). On the other hand, in sitagliptin group, there was greater improvement in lipid profile than pioglitazone group.CONCLUSION:Sitagliptin and Pioglitazone demonstrated similar improvements in glycemic control in type 2 diabetes mellitus patients whose diabetes had been inadequately controlled with metformin. Nevertheless, sitagliptin was more effective than pioglitazone regarding lipid and body weight change.

Association of Maternal Gestational Weight Gain With the Infant Fecal Microbiota.

Pregnancy characteristics may influence the infant fecal microbiota during early life. We aimed to examine associations of maternal gestational weight gain with infant fecal microbiota composition, bacterial community richness, and Shannon diversity index. We analyzed data from a prospective cohort study of healthy infants. We collected prenatal data, including report of mother's gestational weight gain, and infant fecal samples from 84 infant-mother dyads. By applying 16S rRNA gene sequencing and an unbiased clustering by partitioning around medoids using Bray-Curtis distances, we identified 4 fecal microbiota profiles, and examined the associations of maternal gestational weight gain with the 4 fecal microbiota profiles, bacterial community richness, and Shannon diversity index. Overall, the median age of infants was 4.0 months and 43% were girls. The mothers of the 84 infants gained a mean of 14.2 kg (standard deviation, 5.4 kg) during pregnancy. We identified 4 distinct microbiota profiles: Bifidobacterium-dominant (42%), Enterobacter/Veillonella-dominant (23%), Bacteroides-dominant (19%), and Escherichia-dominant (17%). Infants whose mothers had higher gestational weight gain were less likely to have a Bacteroides-dominant profile, corresponding to a relative risk ratio of 0.83 (95% confidence interval, 0.71-0.96; P = 0.01) per 1 kg increase in weight. In addition, higher gestational weight gain was also associated with lower bacterial community richness and Shannon diversity index (P < 0.05). In this prospective cohort study of healthy infants, maternal gestational weight gain was associated with the infant fecal microbiota profiles, bacterial community richness, and Shannon diversity index.

EFFECTS OF L-CARNITINE SUPPLEMENTATION AT FORCED FEEDING PERIOD ON GROWTH PERFORMANCE AND PROXIMATE COMPOSITIONS OF BREAST MUSCLE AND LIVER OF MUSCOVY AND MOULARD DUCKS

An experiment was conducted using 300 ducks of day-old (180 Muscovy and 120 Moulard), based on sexing which was done for 500 ducklings at the first day of age where it was brought up in accordance with the principles of the French care for birds research and rearing of water fowls for fattening purposes until 12 weeks of age. At this age birds were divided within each breed according to feeding regime (forced feeding and ad libitum feeding group), and supplementation of L carnitine (1000 mg kg of diet) making eight groups until the end of the study (at 14 weeks). The results of the experiment revealed that, forced feeding has a significant increase in body weight and absolute or relative weight gain (5954.33 g, 1421.03 g and 23.51%, respectively) than ad libitum feeding (4506.75 g, 411.05 g and 8.94%; respectively). Under the regime of force-feeding Moulard ducks had significantly increased absolute and relative body weight gain (1808.16 g and 29.64%, respectively) than Muscovy ducks (930.67 g and 15.73% respectively). Feed conversion per kg increase in weight was the best in Moulard ducks than Muscovy under force-feeding regime (6.29 kg and 11.5 kg, respectively), and vice versa with the ad libitum feeding (18.89 for 11.06 kg, respectively), at the same time the Moulard ducks needed a larger amount of feed per kg liver, (in forced or ad libitum feeding) than Muscovy. El-Edel M.A. et al., 812 Force-feeding led to severe assembly of fat in the liver, which was significantly higher than in ad libitum feeding groups (57.78% from 35.28%, respectively) and on the contrary, was the percentage of protein (9.66% from 28.81%, respectively). Addition of L carnitine to the feed at forced feeding period resulted in a significant increase in the life weight (5731.97 g) than in non L carnitine fed group(5400.13 g), on the other hand other performance traits not affected significantly by the addition of L carnitine in feed. Liver weight (absolute and Percent) in L carnitine treatment group was higher than non L carnitine group in the ad libitum feeding group (it was not significant). Using L carnitine in ad libitum feeding groups achieved a higher percentage of dry matter in liver (30.88%) than those without L carnitine (28.98%), unlike the breast muscles; dry matter was higher in the group without L carnitine than with L carnitine (32.05% from 30.37%). It would be concluded from this study that using of Moulard duck is preferred for the foie gras production than Muscovy ducks because of its ability to receive large quantity of feed and has the highest feed conversion and a better feed per kg increase in weight as well as the absolute and relative weight of the liver from Muscovy ducks under the forced feeding regime. L carnitine supplementation has no effect on the foie gras production, but if it was added to the feed during the forced feeding period it improved live weight significantly.

Change in weight and waist circumference and risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study.

BackgroundStudies reporting the association between change in weight or body mass index during midlife and risk of colorectal cancer have found inconsistent results, and only one study to date has reported the association between change in waist circumference (a measure of central adiposity) and risk of colorectal cancer.MethodsWe investigated the association between risk of colorectal cancer and changes in directly measured waist circumference and weight from baseline (1990-1994) to wave 2 (2003-2007). Cox regression, with age as the time metric and follow-up starting at wave 2, adjusted for covariates selected from a causal model, was used to estimate the Hazard Ratios (HRs) and 95 % Confidence Intervals (CIs) for the change in waist circumference and weight in relation to risk of colorectal cancer.ResultsA total of 373 cases of colorectal cancer were diagnosed during an average 9 years of follow-up of 20,605 participants. Increases in waist circumference and weight were not associated with the risk of colorectal cancer (HR per 5 cm increase in waist circumference = 1.02; 95 % CI: 0.95, 1.10; HR per 5 kg increase in weight = 0.93; 0.85, 1.02). For individuals with a waist circumference at baseline that was less than the sex-specific mean value there was a slight increased risk of colorectal cancer associated with a 5 cm increase in waist circumference at wave 2 (HR = 1.08; 0.97, 1.21).ConclusionIncreases in waist circumference and weight during midlife do not appear to be associated with the risk of colorectal cancer.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-016-2144-1) contains supplementary material, which is available to authorized users.

Assessment of Anthropometric Indices, Salt Intake and Physical Activity in the Aetiology of Prehypertension

Globally, prehypertension is responsible for approximately 62% of cardiovascular and 49% of ischemic heart disease (IHD) episodes. Current data from the Indian subcontinent suggests that prevalence of prehypertension was 47% amongst young urban residents. Considering its serious prognosis, the current study was undertaken to assess risk factors such as for cardiovascular diseases in prehypertensives adult males in Uttarakhand region. This cross-sectional analytical study was conducted in the Department of Physiology, HIMS, Dehradun, over a period of 12 months. Volunteers (20-40 years) were divided into two groups; Group I (Controls): normotensives and Group II (Cases): prehypertensives based on JNC VII classification. Exercise capacity, determined by peak VO2 consumption was significantly lower in prehypertensive group than the normotensive group (p<0.001). Daily salt intake of pre-hypertensives was significantly greater than the normotensive subjects (p<0.001). Multiple Linear Regression analysis revealed that average baseline SBP increases by 0.34 mmHg for every 1 kg increase in weight and average baseline DBP increases by 0.25 mmHg for every 1 year increase in age. Exercise capacity was found decreased in pre-hypertensives and they have high daily salt intake. Also, weight and age emerged as independent risk factors for SBP and DBP respectively.

Variation in physiological profiles may explain breed differences in neonatal lamb thermoregulation

Ability to adapt rapidly from the uterine environment to self-thermoregulation following birth is a vital requirement for neonatal lamb survival. This investigation reports factors that could explain differences in thermoregulation among breeds that differ in lamb survival. Breeds such as the Merino and Border Leicester have previously been shown to be divergent for birthweight, cold resistance and lamb survival. Cross-bred (Poll Dorset Border Leicester (PDBL, n = 9) and Poll Dorset Merino (PDM, n = 25)) and pure-bred (Border Leicester (BL, n = 35) and Merino (M, n = 46)) lambs were recorded for the thermogenic measures rectal temperature at birth, cold resistance (time for rectal temperature to fall to 35°C while in a cooled water bath) and cold recovery (time to restore rectal temperature after cold exposure) at 1 day of age. In pure-bred lambs, 1 kg increase in weight resulted in a 0.25°C increase in rectal temperature at birth (P &lt; 0.001) and 4.2 min increase in cold resistance (P &lt; 0.001). In contrast, cross-bred lambs did not exhibit any relationship between birthweight and rectal temperature at birth, although they displayed a 3.2 min greater cold resistance for every 1 kg increase in birthweight (P &lt; 0.001). BL-derived lambs were more cold resistant than M lambs (cross-bred: PDBL, 67.1 ± 2.5 min; PDM, 56.4 ± 1.6 min; P &lt; 0.01; and pure-bred: BL, 58.1 ± 1.5 min; M, 53.2 ± 1.3 min; P &lt; 0.01). The quadratic relationship of glucose concentration over time during cold exposure differed with lamb breed. PDBL exhibited higher peak glucose concentrations than did PDM (11.0 mmol/L and 8.9 mmol/L, respectively; P &lt; 0.01). BL took longer to reach peak glucose concentration (50 min) than did M (40 min) and this peak value was higher (BL, 9.4 mmol/L; M, 7.7 mmol/L; P &lt; 0.001). In conclusion, variations in birthweight and glucose metabolism are associated with breed differences in thermogenesis of neonatal lambs.